Lippia sidoides and Myracrodruon urundeuva gel prevents alveolar bone resorption in experimental periodontitis in rats.
In Brazilian folk medicine, Lippia sidoides (Ls) and Myracrodruon urundeuva (Mu) have gained popularity and reputation as effective antimicrobial and anti-inflammatory agents. This work aimed to evaluate the effect of topical herbal gel from Ls 0.5% (v/w) and Mu 5% (w/w) in experimental periodontal disease (EPD) in rats. Wistar rats were subjected to ligature placement around the second upper left molars. Animals were treated topically with Ls and/or Mu-based gel, immediately after EPD induction and three times/day for 11 days until the rats were sacrificed (11th day). Saline-based gel was utilized as control for all experiments and doxycycline based gel 10% (w/w) was utilized as reference substance. Animals were weighed daily. Alveolar bone loss was measured as the difference (in millimeters) between the cusp tip and the alveolar bone. The periodontum and the surrounding gingivae were examined at histopathology, as well as the neutrophil influx into the gingivae was assayed using myeloperoxidase activity and cytokine production mainly tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) levels by ELISA method. The local bacterial flora was assessed through culture of the gingival tissue in standard aerobic and anaerobic media. Alveolar bone loss was significantly inhibited by Ls and Mu combined treatment compared to the saline control group. Ls and Mu combined treatment reduced tissue lesion at histopathology, with partial preservation of the periodontum, coupled to decreased myeloperoxidase activity as well as significantly inhibited TNF-alpha and IL-1beta production in gingival tissue compared to the saline control group. Ls and Mu combined treatment also prevented the growth of oral microorganisms and the weight loss. Ls and Mu combined based gel treatment preserved alveolar bone resorption and demonstrated anti-inflammatory and antibacterial activities in experimental periodontitis.
Botelho
M A
MA
Department of Community Health, Faculty of Medicine, Federal University of Ceará, Rua Professor Costa Mendes, 60.430-270 Fortaleza, Ceará, Brazil. marcobotelho1@gmail.com
Rao
V S
VS
Carvalho
C B M
CB
Bezerra-Filho
J G
JG
Fonseca
S G C
SG
Vale
M L
ML
Montenegro
D
D
Cunha
F
F
Ribeiro
R A
RA
Brito
G A
GA
D016301:Alveolar Bone Loss / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D027926:Anacardiaceae / Q000737:chemistry*; D000818:Animals; D002176:Candida albicans / Q000187:drug effects / Q000302:isolation & purification; D005782:Gels / Q000627:therapeutic use; D005881:Gingiva / Q000187:drug effects / Q000276:immunology / Q000382:microbiology; D053583:Interleukin-1beta / Q000276:immunology; D032411:Lippia / Q000737:chemistry*; D008297:Male; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D010518:Periodontitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009195:Peroxidase / Q000276:immunology; D010936:Plant Extracts / Q000627:therapeutic use; D010938:Plant Oils / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D013291:Streptococcus / Q000187:drug effects / Q000302:isolation & purification; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D005782:Gels; D053583:Interleukin-1beta; D010936:Plant Extracts; D010938:Plant Oils; D014409:Tumor Necrosis Factor-alpha; D009195:Peroxidase